- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 403/00 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patent holdings for IPC class C07D 403/00
Total number of patents in this class: 350
10-year publication summary
|
20
|
8
|
12
|
12
|
14
|
9
|
15
|
7
|
4
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3743 |
12 |
| Janssen Pharmaceutica N.V. | 3413 |
10 |
| Alcon, Inc. | 5394 |
7 |
| Novartis AG | 10883 |
5 |
| Bristol-myers Squibb Company | 4875 |
5 |
| Merck Sharp & Dohme Corp. | 2201 |
5 |
| Boehringer Ingelheim International GmbH | 4698 |
5 |
| Genentech, Inc. | 3968 |
4 |
| Merck Patent GmbH | 5850 |
4 |
| Idemitsu Kosan Co., Ltd. | 4166 |
4 |
| Rigel Pharmaceuticals, Inc. | 539 |
4 |
| Sichuan Haisco Pharmaceutical Co., Ltd. | 151 |
4 |
| Kymera Therapeutics, Inc. | 227 |
4 |
| Centre National de La Recherche Scientifique | 10350 |
3 |
| Amgen Inc. | 4055 |
3 |
| Vertex Pharmaceuticals Incorporated | 1598 |
3 |
| Alexion Pharmaceuticals, Inc. | 636 |
3 |
| Array BioPharma Inc. | 505 |
3 |
| ChemoCentryx, Inc. | 389 |
3 |
| Cynora GmbH | 202 |
3 |
| Other owners | 256 |